Researchers: Cannabinoids Provide Modest Analgesic Benefit for Central Neuropathic Pain

As Dr. Meng reported at the 2016 annual meeting of the American Society of Regional Anesthesia and Pain Medicine (abstract 2909), management of chronic neuropathic pain with available pharmacotherapy is associated with a high failure rate.

“Given the void of effective therapy, there’s been an increase in use and popularity of cannabis and cannabinoid for treating this type of pain,” Dr. Meng said. “The concern that we have, however, is that recent pain guidelines provide contradictory recommendations.”